About GaBI last update 01/12/2009

GaBI aims to foster the worldwide efficient use of high-quality and safe medicines at an affordable price, thus advancing and supporting the idea of accessible, affordable and sustainable healthcare. Eventually it will provide an umbrella for a range of educational and publishing activities. This includes an online news and information exchange platform – GaBI Online.

The GaBI Online platform aims to be a one-stop portal containing news, a repository of worldwide guidelines and an archive of related scientific information. It seeks to provide readers with the latest updates on developments in relation to generic and biosimilar medicines, and to serve as a communication vehicle to reach key members of the healthcare world.

“The intention of GaBI is to generate a service for healthcare providers to support them in making cost-effective choices when it comes to treatment decisions. I see that as a noble objective,” comments Professor Vulto. He stresses that healthcare professionals – such as physicians and pharmacists – are the primary target of GaBI, followed by others involved in sustaining healthcare, such as healthcare policy and drug regulators, third-party payers, and the pharmaceutical industry.

About GaBI Online

The GaBI Online platform (launched in September 2009) aims to be a one-stop portal containing news, a repository of worldwide guidelines and an archive of related scientific information. It seeks to provide readers with the latest updates on developments in relation to generic and biosimilar medicines, and to serve as a communication vehicle to reach key members of the healthcare world.

GaBI Online subscribers can stay informed by receiving regular online alerts on the latest news, reports on drug development, related scientific events, and more.

For more information please contact Ms Lasia Tang via: LTang@gabionline.net.